Hochschulschrift
Theranostic nuclear oncology in the management of metastatic cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
48 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen
Rheinische Friedrich-Wilhelms-Universität Bonn, Habilitationsschrift, 2020
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- 2020
Ähnliche Objekte (12)
CD38 as theranostic target in oncology
Imaging Recommendations for Theranostic PET-CT in Oncology
Correction to: CD38 as theranostic target in oncology
Nuclear oncology
Advancements in PARP1 targeted nuclear imaging and theranostic probes
New Theranostic Radionuclides for Metastatic Bone Disease : Biodistribution and Dosimetric Analysis
The Theranostic Genome
The theranostic potentialities of bioavailable nanocurcumin in oral cancer management
Theranostic Hybrid Molecular Imaging
Dendrimers for theranostic applications
High yield cyclotron production of a novel 133/135La theranostic pair for nuclear medicine
Targeted theranostic photoactivation on atherosclerosis
CD38 as theranostic target in oncology
Imaging Recommendations for Theranostic PET-CT in Oncology
Correction to: CD38 as theranostic target in oncology
Nuclear oncology
Advancements in PARP1 targeted nuclear imaging and theranostic probes
New Theranostic Radionuclides for Metastatic Bone Disease : Biodistribution and Dosimetric Analysis
The Theranostic Genome
The theranostic potentialities of bioavailable nanocurcumin in oral cancer management
Theranostic Hybrid Molecular Imaging
Dendrimers for theranostic applications
High yield cyclotron production of a novel 133/135La theranostic pair for nuclear medicine
Targeted theranostic photoactivation on atherosclerosis
CD38 as theranostic target in oncology
Imaging Recommendations for Theranostic PET-CT in Oncology
Correction to: CD38 as theranostic target in oncology
Nuclear oncology
Advancements in PARP1 targeted nuclear imaging and theranostic probes
New Theranostic Radionuclides for Metastatic Bone Disease : Biodistribution and Dosimetric Analysis
The Theranostic Genome
The theranostic potentialities of bioavailable nanocurcumin in oral cancer management
Theranostic Hybrid Molecular Imaging
Dendrimers for theranostic applications
High yield cyclotron production of a novel 133/135La theranostic pair for nuclear medicine